H.R. 979 was introduced in the 112th Congress, which has adjourned.

It has not yet been reintroduced.

You can increase the chances that the bill is revived in the new Congress by showing support for reintroduction.

Want to be notified when this bill is reintroduced?

View H.R. 979 (112th) report

What’s your position on H.R. 979 (112th)?

H.R. 979: FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Summary: To amend chapter 89 of title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefits Program. (More Info)

H.R. 979 was introduced in the 112th Congress, which has adjourned. It has not yet been reintroduced.

What POPVOX Users Say

POPVOX Nation:
100% Support
0% Oppose
(1 user)

View Report & Comments

1 users
0 users
order determined by social media popularity

Endorsing Organizations

National Treasury Employees Union (NTEU) 3,122 Facebook fans 526 Twitter followers

Representative Stephen Lynch (D-MA) introduced H.R. 979, on March 9, 2011. The bill is intended to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under FEHBP. At the present time, pharmacy benefit managers (PBMs) negotiate drug prices with the pharmaceutical manufacturers who offer rebates and discounts. In a complicated process, the PBMs offer prescription drugs to the insurance carriers at what are supposed to be discounted rates. The insurance carriers contract with OPM to run their health plans as part of FEHBP, however the FEHBP program is not receiving the benefits ...

Read full position statement.

* This organization’s position on this bill was entered by POPVOX.